225 related articles for article (PubMed ID: 8747752)
21. The nitric oxide synthase inhibitor L-NAME (N omega-nitro-L-arginine methyl ester) does not produce discriminative stimulus effects similar to ethanol.
Green KL; Gatto GJ; Grant KA
Alcohol Clin Exp Res; 1997 May; 21(3):483-8. PubMed ID: 9161609
[TBL] [Abstract][Full Text] [Related]
22. Methadone's effects on pentylenetetrazole-induced seizure threshold in mice: NMDA/opioid receptors and nitric oxide signaling.
Kazemi Roodsari S; Bahramnejad E; Rahimi N; Aghaei I; Dehpour AR
Ann N Y Acad Sci; 2019 Aug; 1449(1):25-35. PubMed ID: 30957236
[TBL] [Abstract][Full Text] [Related]
23. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat.
Redwine KE; Trujillo KA
Pharmacol Biochem Behav; 2003 Sep; 76(2):361-72. PubMed ID: 14592689
[TBL] [Abstract][Full Text] [Related]
24. Drugs used in the treatment of opioid tolerance and physical dependence: a review.
Raith K; Hochhaus G
Int J Clin Pharmacol Ther; 2004 Apr; 42(4):191-203. PubMed ID: 15124977
[TBL] [Abstract][Full Text] [Related]
25. Antiexudative effects of opioids and expression of kappa- and delta-opioid receptors during intestinal inflammation in mice: involvement of nitric oxide.
Jiménez N; Puig MM; Pol O
J Pharmacol Exp Ther; 2006 Jan; 316(1):261-70. PubMed ID: 16183704
[TBL] [Abstract][Full Text] [Related]
26. Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia.
Nishiyama T
Can J Anaesth; 2000 Jul; 47(7):693-8. PubMed ID: 10930211
[TBL] [Abstract][Full Text] [Related]
27. The role of nitric oxide in the development of morphine tolerance in rat hippocampal slices.
Lue WM; Su MT; Lin WB; Tao PL
Eur J Pharmacol; 1999 Oct; 383(2):129-35. PubMed ID: 10585526
[TBL] [Abstract][Full Text] [Related]
28. [Effect of nitric oxide synthase inhibitor on signal transduction pathway of opiate tolerance and dependence in NG108-15 cells expressing iNOS gene].
Zang M; Shen Q; Liu J
Zhonghua Yi Xue Za Zhi; 1999 Oct; 79(10):764-8. PubMed ID: 11715524
[TBL] [Abstract][Full Text] [Related]
29. Involvement of NMDA receptors and nitric oxide in the thermoregulatory effect of morphine in mice.
Ulugol A; Dost T; Dokmeci D; Akpolat M; Karadag CH; Dokmeci I
J Neural Transm (Vienna); 2000; 107(5):515-21. PubMed ID: 11072747
[TBL] [Abstract][Full Text] [Related]
30. NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats.
Mendez IA; Trujillo KA
Psychopharmacology (Berl); 2008 Feb; 196(3):497-509. PubMed ID: 17994223
[TBL] [Abstract][Full Text] [Related]
31. Clinical benefits and risks of N-methyl-d-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review.
Fluyau D; Revadigar N; Pierre CG
Drug Alcohol Depend; 2020 Mar; 208():107845. PubMed ID: 31978670
[TBL] [Abstract][Full Text] [Related]
32. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
Kotlińska J
Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
[TBL] [Abstract][Full Text] [Related]
33. Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance?
King T; Ossipov MH; Vanderah TW; Porreca F; Lai J
Neurosignals; 2005; 14(4):194-205. PubMed ID: 16215302
[TBL] [Abstract][Full Text] [Related]
34. N-methyl-D-aspartate-mediated glutamate toxicity in the developing rabbit retina.
Haberecht MF; Mitchell CK; Lo GJ; Redburn DA
J Neurosci Res; 1997 Feb; 47(4):416-26. PubMed ID: 9057135
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of NMDA and AMPA glutamate receptors elicits distinct concentration dynamics of nitric oxide in rat hippocampal slices.
Frade JG; Barbosa RM; Laranjinha J
Hippocampus; 2009 Jul; 19(7):603-11. PubMed ID: 19115375
[TBL] [Abstract][Full Text] [Related]
36. Lack of morphine and enkephalin tolerance in 129/SvEv mice: evidence for a NMDA receptor defect.
Kolesnikov Y; Jain S; Wilson R; Pasternak GW
J Pharmacol Exp Ther; 1998 Feb; 284(2):455-9. PubMed ID: 9454784
[TBL] [Abstract][Full Text] [Related]
37. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice.
Wiley JL; Cristello AF; Balster RL
Eur J Pharmacol; 1995 Dec; 294(1):101-7. PubMed ID: 8788421
[TBL] [Abstract][Full Text] [Related]
38. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.
Rasmussen K; Fuller RW; Stockton ME; Perry KW; Swinford RM; Ornstein PL
Eur J Pharmacol; 1991 May; 197(1):9-16. PubMed ID: 1832640
[TBL] [Abstract][Full Text] [Related]
39. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
[TBL] [Abstract][Full Text] [Related]
40. Sedative but not analgesic alpha2 agonist tolerance is blocked by NMDA receptor and nitric oxide synthase inhibitors.
Davies MF; Reid K; Guo TZ; Agashe GS; Amin YK; Maze M
Anesthesiology; 2001 Jul; 95(1):184-91. PubMed ID: 11465557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
